ArticleOncoTargets and therapy2021

Alectinib Together with Intracranial Therapies Improved Survival Outcomes in Untreated ALK-Positive Patients with Non-Small-Cell Lung Cancer and Symptomatic and Synchronic Brain Metastases: A Retrospective Study.

Qiang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.